Form D · Other Health Care
AeroRx Therapeutics, Inc.
La Jolla, CA · CIK 0002090778
Offering snapshot reported Oct 10, 2025 · SEC filing
- Reported sold
- $10.4M Offering amount: $20.8M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 10, 2025 | Initial | $10,376,003 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-560436
Source: Form D, filed Oct 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jay B. Lichter, Ph.D. | Director |
| Sanford Madigan, Ph.D. | Director |
| John Stuart Patton, Ph.D. | Director |
| Heather Preston, M.D. | Director |
| Tighe Reardon | Executive |
| Ahmet Tutuncu, M.D., Ph.D. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11099 North Torrey Pines Rd, Suite 290
La Jolla, CA, 92037
La Jolla, CA, 92037